Chile

BMI Core View: Drugmakers based in emerging markets will expand their presence in developed countries. Firms in developing countries enjoy low operating costs but have historically... 2011-11-10

BMI View: While we believe Chile's pharmaceutical industry is short-sighted and self-serving in its opposition to new government bioequivalence certification standards, we concede that... 2011-11-04

BMI View: Bucking a global push towards over-the-counter (OTC) medicines, governments across Latin America have responded to a series of scandals by clamping down on pharmacy sales.... 2011-10-28

BMI View: Although testament to the region's increasing growth potential, we believe foreign investments into pharmacy chains and local pharmaceutical companies have far-reaching implications... 2011-10-19

BMI View: Despite copper exports driving Chile's solid economic growth, the country's continuing struggle with social inequality has left many citizens struggling to meet their healthcare... 2011-10-03

BMI View: We see Teuto's decision to focus on advanced drug manufacturing systems, along with its product portfolio of innovative and generic medicines, as a further improvement in... 2011-09-23

BMI View: While BMI does not expect Chile's government to drastically raise financial penalties or introduce new regulations, we believe the media frenzy and apparent public outrage... 2011-09-21